515157-47-8

Basic information

• Product Name: Borinic acid, bis(3-chloro-4-methylphenyl)-
• CAS NO: 515157-47-8
• Molecular Formula: C14H13BCl2O
• Molecular Weight: 278.974
• Mol File: 515157-47-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Borinic acid, bis(3-chloro-4-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Borinic acid, bis(3-chloro-4-methylphenyl)-(515157-47-8)
• EPA Substance Registry System: Borinic acid, bis(3-chloro-4-methylphenyl)-(515157-47-8)

Safety Data

• Hazardous Substances Data: 515157-47-8(Hazardous Substances Data)

Upstream product

• 89794-02-5 4-bromo-2-chlorotoluene 
• 7732-18-5 water 
• 22092-92-8 diisopropopylaminoborane 
• 515158-85-7 3-chloro-4-methylphenyl magnesium bromide 
• 121-43-7 Trimethyl borate 
• 83846-48-4 3-chloro-4-methyliodobenzene 

Downstream Products

• 872044-70-7 3-hydroxypyridine-2-carbonyloxy-bis(3-chloro-4-methylphenyl)borane 
• 1181749-33-6 di(3-chloro-4-methylphenyl)-2-aminoethylthioborane 
• 872044-93-4 bis(3-chloro-4-methylphenyl)borinic acid 1-benzyl-4-(hydroxymethyl) imidazole ester 

Relevant articles and documents

Borinic Acids via Direct Arylation of Amine-Borane Complexes: An Air- and Water-Stable Boron Source

A synthesis of borinic acids and borinates was optimized using amine-borane complexes as a water and air insensitive borylating agent. The reaction operates under convenient conditions using a non-cryogenic temperature and with no flash chromatography, and it gives no boron impurities. The reaction proceeds through a tandem dehydrogenation-double addition mechanism.

PROCESS FOR MANUFACTURING PICOLINATE BORINIC ESTERS

The present invention relates to the field of boron-containing compounds, particularly boron compounds and pharmaceutical compositions thereof that exhibit with antibacterial and/or anti-inflammatory activities, and uses thereof. Methods for preparing and

Antibiotics containing borinic acid complexes and methods of use

The structure and preparation of antibiotics incorporating borinic acid complexes are disclosed, especially hydroxyquinoline, imidazole and picolinic acid derivatives, along with compositions of these antibiotics and methods of using the antibiotics and compositions as bactericidal and fungicidal agents as well as therapeutic agents for the treatment of diseases caused by bacteria and fungi.